|Alexandra Okmian Sanderovich||Senior Business Development and Investor Relations Manager|
|Dror Ben-Asher||Chief Executive Officer|
|Guy Goldberg||Chief Business Officer|
|Gilead Raday||Chief Operating Officer|
|Rob Jackson||Senior VP, Sales & Marketing|
|Micha Ben Chorin||Chief Financial Officer|
|Brandon Folkes||Cantor Fitzgerald|
|Boobalan Pachaiyappan||H.C. Wainwright|
Good day and welcome to the RedHill Biopharma’s Fourth Quarter and Full Year 2021 Financial Results Conference Call. All participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions] At this time, I would like to introduce the conference call, RedHill’s CEO, Dror Ben-Asher; Guy Goldberg, Chief Business Officer; Gilead Raday, Chief Operating Officer; Rob Jackson, Senior VP Sales & Marketing; Rick Scruggs, Chief Commercial Officer; and Micha Ben Chorin, Chief Financial Officer.
We have additional senior management team members available to answer questions during the Q&A session, including; Dr.